Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

136

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C10AA05	ATORVASTATINE ARROW GENERQUES	G	Atorvastatin - 40mg	40mg	Tablet, coated	564,414 L.L
J01CR02	BETAMOX PLUS	G	Amoxicillin - 875mg, Clavulanic Acid - 125mg		Tablet, coated	717,661 L.L
R05FA01	NEO-CODION	B	Codeine Camphosulfonate - 25mg, Sulfogaiacol - 100mg, Grindelia soft extract - 20mg		Tablet, coated	258,018 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 25mg	25mg	Tablet, coated	1,744,308 L.L
L01EB01	GEFITINIB ARROW	G	Gefitinib - 250mg	250mg	Tablet, coated	85,330,070 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 25mg	25mg	Tablet, coated	1,744,308 L.L
L01EB01	GEFITINIB BIOGARAN	G	Gefitinib - 250mg	250mg	Tablet, coated	87,070,893 L.L
L02BG03	ANASTROZOLE BIOGARAN	G	Anastrozole - 1mg	1mg	Tablet, coated	3,800,387 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 25mg	25mg	Tablet, coated	1,744,308 L.L
C03DA04	EPLERENONE BIOGARAN	G	Eplerenone - 25mg	25mg	Tablet, coated	1,849,127 L.L
C03DA04	HEPERONA 25	G	Eplerenone - 25mg	25mg	Tablet, coated	2,116,552 L.L
C10AA05	TORVACOL 40	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, coated	2,363,819 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 50mg	50mg	Tablet, coated	1,744,308 L.L
M01AB05	RAPIDUS	G	Diclofenac potassium - 50mg	50mg	Tablet, coated	287,582 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 50mg	50mg	Tablet, coated	1,744,308 L.L
C03DA04	EPLERENONE ARROW	G	Eplerenone - 50mg	50mg	Tablet, coated	1,744,308 L.L
C10AA05	ATORVASTATINE ARROW GENERIQUES	G	Atorvastatin - 80mg	80mg	Tablet, coated	564,414 L.L
P01BA02	DOLQUINE	G	Hydroxychloroquine sulfate - 200mg	200mg	Tablet, coated	1,191,988 L.L
V03AC03	DEFERASIROX ARROW	G	Deferasirox - 90mg	90mg	Tablet, coated	8,846,092 L.L
C03DA04	EPLERENONE BIOGARAN	G	Eplerenone - 50mg	50mg	Tablet, coated	1,849,127 L.L
C10AA05	ATORVASTATINE ARROW GENERIQUES	G	Atorvastatin - 80mg	80mg	Tablet, coated	564,414 L.L
C03DA04	HEPERONA 50	G	Eplerenone - 50mg	50mg	Tablet, coated	2,150,148 L.L
V03AC03	DEFERASIROX ARROW	G	Deferasirox - 180mg	180mg	Tablet, coated	9,056,837 L.L
L02BG04	LETROZOLE ARROW LAB	G	Letrozole - 2.5mg	2.5mg	Tablet, coated	2,000,981 L.L
L02BG04	LETROZOLE BIOGARAN	G	Letrozole - 2.5mg	2.5mg	Tablet, coated	2,402,790 L.L
V03AC03	DEFERASIROX ARROW	G	Deferasirox - 360mg	360mg	Tablet, coated	13,019,366 L.L
G04BE08	TADALAFIL BIOGARAN	G	Tadalafil - 5mg	5mg	Tablet, coated	3,369,013 L.L
L02BG06	EXEMESTANE BGR	G	Exemestane - 25mg	25mg	Tablet, coated	4,479,027 L.L
M01AB55	DIFEN PLUS	G	Diclofenac potassium - 50mg, Betamethasone - 0.3mg		Tablet, coated	503,941 L.L
C10AA07	SUPERSTAT	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, coated	517,379 L.L

...

136

...